Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe

Authors:	Inge G.P. Geelen Noortje Thielen Jeroen J.W.M. Janssen Mels Hoogendoorn Tanja J.A. Roosma Peter J.M. Valk Otto Visser Jan J. Cornelissen Peter E. Westerweel

Affiliation:	1. Department of Hematology, Albert Schweitzer Hospital, Dordrecht, The Netherlands;2. Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands;3. Department of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands;4. Department of Hematology, Medical Center Leeuwarden, Leeuwarden, The Netherlands;5. Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands;6. Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands

Abstract:

Keywords:	molecular cytogenetics myeloproliferative neoplasms philadelphia chromosome